Menu

Drug manufacturers and a drug industry vendor recently urged a Washington D.C. federal court in various lawsuit filings to reject hospitals and the government’s arguments against implementing a 340B rebate model.

Drugmakers Ask Court to Rule in Favor of 340B Rebate Model, Reject Hospitals’ Arguments; Kalderos Opposes 340B Health’s Amicus Brief

April 10, 2025 Shannon Young, Associate Editor/Senior Writer 340B Report Views

Four major drug manufacturers and a drug industry vendor recently urged a Washington D.C. federal court to reject the government [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

J&J Adds Unbranded Version of Stelara to 340B Contract Pharmacy Restrictions

Part 2 of a 4-Part Series: A Look Into 340B’s Changing Landscape and Whether AI Can Be the Solution